Compounds > isoproterenol

isoproterenol and urapidil

isoproterenol has been researched along with urapidil in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19905 (50.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Graham, BR; Prichard, BN; Renondin, JC; Tomlinson, B1
Flanagan, PH; Galbraith, H; Jackson, SH; Jamieson, MJ; Patel, SS; Shepherd, AM; Stewart, W1
Flanagan, PH; Galbraith, H; Jackson, SH; Jamieson, MJ; Patel, SS; Shepherd, AM1
Rand, MJ; Verberne, AJ1
Bielefeld, FW; Schümann, HJ1
Freissmuth, M; Schütz, W; Steurer, G; Tuisl, E1
Frenguelli, BG; Pearson, T1

Trials

2 trial(s) available for isoproterenol and urapidil

ArticleYear
The assessment of the beta-blocking activity of urapidil: a new method.
    European journal of clinical pharmacology, 1986, Volume: 31, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Heart Rate; Humans; Isoproterenol; Male; Piperazines; Propranolol; Random Allocation

1986
Alpha adrenergic blocking activity of urapidil in man.
    Research communications in chemical pathology and pharmacology, 1988, Volume: 62, Issue:2

    Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Norepinephrine; Phenylephrine; Piperazines

1988

Other Studies

8 other study(ies) available for isoproterenol and urapidil

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
    European journal of clinical pharmacology, 1991, Volume: 41, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Phenylephrine; Piperazines

1991
Effect of urapidil on beta-adrenoceptors of rat atria.
    European journal of pharmacology, 1985, Jan-22, Volume: 108, Issue:2

    Topics: Animals; Antihypertensive Agents; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta

1985
The effect of urapidil on cardiac alpha- and beta-adrenoceptors.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:10

    Topics: Animals; Clonidine; Drug Interactions; Female; Fenoterol; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Norepinephrine; Phenylephrine; Piperazines; Rabbits; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta

1986
Interaction of the antihypertensive drug urapidil with cardiac beta-adrenoceptors in vitro.
    European journal of pharmacology, 1984, Sep-03, Volume: 104, Issue:1-2

    Topics: Adenylyl Cyclases; Animals; Antihypertensive Agents; Binding, Competitive; Enzyme Activation; Guinea Pigs; Heart; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Myocardium; Pindolol; Piperazines; Receptors, Adrenergic, beta

1984
Adrenoceptor subtype-specific acceleration of the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampus.
    The European journal of neuroscience, 2004, Volume: 20, Issue:6

    Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Drug Interactions; Excitatory Postsynaptic Potentials; Female; Hippocampus; Hypoxia; In Vitro Techniques; Isoproterenol; Male; Neural Inhibition; Neurons; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Synaptic Transmission; Time Factors; Yohimbine

2004